16-29971508-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000279396.11(TMEM219):c.686C>T(p.Pro229Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000638 in 1,613,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P229R) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000279396.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM219 | NM_001083613.2 | c.686C>T | p.Pro229Leu | missense_variant | 5/6 | ENST00000279396.11 | NP_001077082.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM219 | ENST00000279396.11 | c.686C>T | p.Pro229Leu | missense_variant | 5/6 | 1 | NM_001083613.2 | ENSP00000279396.6 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152000Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000321 AC: 8AN: 249490Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135348
GnomAD4 exome AF: 0.0000623 AC: 91AN: 1461744Hom.: 0 Cov.: 31 AF XY: 0.0000564 AC XY: 41AN XY: 727178
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152000Hom.: 0 Cov.: 31 AF XY: 0.0000808 AC XY: 6AN XY: 74240
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.686C>T (p.P229L) alteration is located in exon 5 (coding exon 4) of the TMEM219 gene. This alteration results from a C to T substitution at nucleotide position 686, causing the proline (P) at amino acid position 229 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at